In the intricate process of pharmaceutical drug synthesis, the selection and quality of chemical intermediates play a pivotal role. 1-O-Acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose, identified by CAS number 6974-32-9, is one such compound that holds significant strategic importance. This high-purity chemical is a cornerstone for the production of various nucleoside analogs, which are vital components in the development of life-saving antiviral and anti-cancer medications. As a dedicated manufacturer and supplier in China, we are committed to ensuring the reliable availability of this critical material for the global pharmaceutical industry.

Our expertise lies in producing 1-O-Acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose with a guaranteed purity of 97%min. This meticulous attention to purity is fundamental, as it directly impacts the efficacy and safety profile of the final drug product. The compound's chemical identity is well-established: its molecular formula is C28H24O9, with a molecular weight of 504.48, and it typically presents as a fine white powder. These characteristics, coupled with our robust manufacturing processes, make us a go-to source for companies seeking to purchase this intermediate for their research and production needs. We are a trusted supplier that understands the pharmaceutical value chain.

We recognize that cost-effectiveness is as important as quality in pharmaceutical procurement. Therefore, as a direct manufacturer, we are able to offer competitive pricing for 1-O-Acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose. This allows our clients to optimize their budget for R&D and manufacturing without compromising on the quality of their raw materials. Whether you require a small quantity for laboratory synthesis or large-scale production batches, our supply chain is designed for efficiency and responsiveness. We encourage all procurement managers and research scientists to inquire about our product and explore the benefits of a direct partnership.

The continuous advancements in antiviral and anti-cancer therapies underscore the ongoing demand for high-quality intermediates like CAS 6974-32-9. By partnering with us, you ensure access to a critical building block manufactured to exacting standards, thereby facilitating your contribution to medical progress. Our commitment to quality, combined with our strong manufacturing capabilities in China, positions us as an ideal partner for your pharmaceutical intermediate needs.